Nestlé makes Atrium move
This article was originally published in OTC Bulletin & The Rose Sheet
Nestlé has signalled its intention to become a force in consumer healthcare by acquiring Canadian supplements specialist Atrium Innovations for US$2.3 billion (€1.95 billion) from a group of investors led by Permira Funds. Subject to regulatory approval, the transaction is expected to close in the first quarter of 2018.
You may also be interested in...
Marketer long known for iconic Hershey's Kisses and other candy products looks to grow its nutritional market revenues with One Brands' products, complementing its Oatmega business and following its investment earlier in August in UK/Ireland maker of protein bars.
In line with its nutrition, health and wellness strategy, Nestlé has bolstered its consumer health offering with ChromaDex’ innovative energy boosting supplement.